Tatyana Matveeva, PhD

Mass General Hospital
Director of CGMP Operations, Regenerative Cell Therapy, Neurosurgery
Tatyana Matveeva, PhD, Director of cGMP Operations, Cell Therapy,
Neurosurgery, Mass General Hospital

Neurodegenerative conditions are prevalent and devastating diseases with severe economic, personal, and healthcare expense consequences. Cell replacement therapies have offered a route to functional recovery, but clinical cell manufacturing frequently requires distributed production and oversight associated with substantial financial burden. The present report will outline an in-hospital cGMP cell manufacturing facility with adjacent quality control and in direct proximity to patients, and demonstrate the challenges of developing a compliant and all-inclusive program at cost.

Related Articles

Mentorship as Service: Tatyana Matveeva on Shaping the Next Generation of ISPE Professionals
iSpeak Blog
Mentorship as Service: Tatyana Matveeva on Shaping the Next Generation of ISPE Professionals

Mentorship plays an essential role in sustaining and advancing the life sciences and pharmaceutical engineering industries. As new professionals enter an increasingly complex and specialized field, guidance from experienced practitioners can help transform academic knowledge into real‑world impact. ISPE has long recognized this need, fostering programs that connect students and early‑career...